KIN - キングスト―ン・カンパニ―ズ （Kindred Biosciences Inc.）

Kindred Biosciences Inc (KIN) shares closed today at 0.5% below its 52 week high of $9.28, giving the company a market cap of $419M. The stock is currently up 114.2% year-to-date, up 125.1% over the past 12 months, and up 126.2% over the past five years. This week, the Dow Jones Industrial Average fell 1.0%, and the S&P 500 fell 1.2%. Trading Activity Trading volume this week was 25.5% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.9. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold.The stock closed at 0.0% lower than its 5-day moving average, 0.4% higher than its 20-day moving average, and 27.5% higher than its 90-day moving average. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 249.1% The company's stock price performance over the past 12 months beats the peer average by 165.4% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

Related Stocks: PFE , GDX , KIN , PRTA , BABA , VIR , ALT , F , PSFE , DISCA , EQ , VIAC , FMS , CVS , LOW , TGT , MRVL , FGEN ,

Kindred Biosciences Inc (KIN) shares closed today at 0.5% below its 52 week high of $9.28, giving the company a market cap of $419M. The stock is currently up 114.2% year-to-date, up 125.1% over the past 12 months, and up 126.2% over the past five years. This week, the Dow Jones Industrial Average fell 1.0%, and the S&P 500 fell 1.2%. Trading Activity Trading volume this week was 25.5% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.9. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold.The stock closed at 0.0% lower than its 5-day moving average, 0.4% higher than its 20-day moving average, and 27.5% higher than its 90-day moving average. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 249.1% The company's stock price performance over the past 12 months beats the peer average by 165.4% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

Related Stocks: PFE , GDX , KIN , PRTA , BABA , VIR , ALT , F , PSFE , DISCA , EQ , VIAC , FMS , CVS , LOW , TGT , MRVL , FGEN ,

Kindred Biosciences Inc (KIN) shares closed today at 100.0% below its 52 week high of $9.28, giving the company a market cap of $412M. The stock is currently up 111.6% year-to-date, up 119.2% over the past 12 months, and up 140.6% over the past five years. This week, the Dow Jones Industrial Average fell 0.5%, and the S&P 500 fell 1.0%. Trading Activity Trading volume this week was 23.7% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.0. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 364.7% The company's stock price performance over the past 12 months beats the peer average by 240.3% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

Kindred Biosciences Inc (KIN) shares closed today at 100.0% below its 52 week high of $9.28, giving the company a market cap of $412M. The stock is currently up 111.6% year-to-date, up 119.2% over the past 12 months, and up 140.6% over the past five years. This week, the Dow Jones Industrial Average fell 0.5%, and the S&P 500 fell 1.0%. Trading Activity Trading volume this week was 22.2% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.0. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 364.7% The company's stock price performance over the past 12 months beats the peer average by 240.3% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

Kindred Biosciences Inc (KIN) shares closed today at 0.9% below its 52 week high of $9.28, giving the company a market cap of $415M. The stock is currently up 113.0% year-to-date, up 136.0% over the past 12 months, and up 146.8% over the past five years. This week, the Dow Jones Industrial Average rose 0.6%, and the S&P 500 rose 0.8%. Trading Activity Trading volume this week was 87.6% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.0. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 280.6% The company's stock price performance over the past 12 months beats the peer average by 194.0% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.